• AngII-Induced M1 Macrophage Polarization via Cx43/NF-κB Path

  2026-07-02

  This study elucidates how angiotensin II drives pro-inflammatory M1 macrophage polarization through the connexin 43 (Cx43)/NF-κB (p65) signaling axis. The findings provide mechanistic clarity for researchers investigating immune modulation and highlight the use of selective Cx43 hemichannel blockers as a tool for dissecting inflammatory pathways.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Advanced Strategies

  2026-07-02

  Explore how the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enhances neuroinflammation and gut–brain axis research through superior signal amplification and specificity. This in-depth analysis reveals protocol optimizations and assay decisions inspired by recent advances in depression models.

• CXCR4-Targeted Theranostics in Lymphoma: Imaging and Precisi

  2026-07-01

  This review highlights recent advances in CXCR4-targeted imaging and therapeutic agents for lymphoma, emphasizing their integration into precision oncology. The findings demonstrate that leveraging CXCR4 overexpression enables both enhanced diagnostic accuracy and new avenues for targeted intervention in aggressive hematologic malignancies.

• V5 Epitope Tag Peptide: Precision Tag for Protein Detection

  2026-07-01

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST peptide) enables high-specificity tagging of recombinant proteins for Western blotting, immunoprecipitation, and advanced imaging. Its robust solubility and validated antibody recognition facilitate reproducible and efficient protein detection across molecular biology workflows.

• 1-myristoylglycerophosphocholine for Lipid Signaling & Fibro

  2026-06-30

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) empowers researchers to dissect lipid-driven signaling in smooth muscle and fibrosis models with superior solubility and reproducibility. Recent mechanistic advances reveal its pivotal role in fibroblast activation, offering new experimental leverage in disease modeling and pathway analysis.

• Olsalazine Sodium as a Mesalamine Dimer in Cancer and Vector

  2026-06-30

  Olsalazine Sodium stands out as a versatile mesalamine dimer for both inflammation and cancer models, as well as pioneering xenobiotic transport studies in mosquitoes. This article demystifies applied workflows, protocol choices, and troubleshooting for maximizing its impact in advanced research.

• Ceapin-A7: A Selective ER Stress Blocker for ATF6α Pathway R

  2026-06-29

  Ceapin-A7 is a potent, selective blocker of endoplasmic reticulum (ER) stress signaling, specifically inhibiting the ATF6α pathway. This compound enables precise dissection of unfolded protein response (UPR) mechanisms in cell biology research. Its high selectivity and favorable storage profile make it a preferred tool for investigating ER stress-driven pathologies.

• Acetylcholine Chloride in Gut-Brain Axis: Protocols & Pitfal

  2026-06-29

  Acetylcholine Chloride enables high-fidelity modeling of gut-brain cholinergic signaling, powering translational research into pediatric refractory epilepsy and autonomic neuroscience. This practical guide distills actionable workflows, troubleshooting insights, and key innovations derived from recent microbiota-brain axis breakthroughs.

• V5 Epitope Tag Peptide: Precision, Dynamics, and Next-Gen Pr

  2026-06-28

  Explore the scientific depth of the V5 Epitope Tag Peptide in recombinant protein research. This article reveals how innovative antibody screening and dynamic detection workflows enable new possibilities for protein tagging and analysis.

• Pentoxifylline Downregulates ICAM-1 in Monocytes In Vivo and

  2026-06-27

  Neuner et al. (1997) demonstrated that pentoxifylline significantly suppresses ICAM-1 expression in human monocytes, both in vivo and in vitro, via TNF-α dependent pathways. This research clarifies one molecular mechanism behind pentoxifylline’s anti-inflammatory action and provides a foundation for targeted modulation of monocyte activity in immune and inflammatory models.

• Pyridostatin TFA: Transforming G-Quadruplex Research and Dis

  2026-06-26

  Explore how Pyridostatin TFA, a leading G-quadruplex DNA structure stabilizer from APExBIO, is reshaping translational research in cancer and neurodegeneration. This article synthesizes mechanistic insights, protocol guidance, and strategic advice, highlighting the evolving clinical and experimental landscape and offering a forward-looking vision for next-generation therapeutic discovery.

• DMG-PEG2000-NH2: NH2-PEG Derivative for Advanced Drug Delive

  2026-06-26

  DMG-PEG2000-NH2 is a primary amine-functionalized PEG linker that enables efficient amide bond formation for lipid nanoparticle (LNP) and liposomal drug delivery systems. Its use enhances solubility, stability, and biocompatibility of therapeutic conjugates, as verified by both product data and recent peer-reviewed research.

• Chemerin in cNTS Elevates Sympathetic Activity via Superoxid

  2026-06-25

  This study reveals that chemerin within the caudal nucleus tractus solitarius (cNTS) elevates sympathetic outflow and blood pressure by activating a CMKLR1-NADPH oxidase-superoxide signaling cascade. The work delineates the specificity of central glutamatergic pathways in cardiovascular regulation, clarifying the distinct roles of NMDA versus non-NMDA receptors.

• Spleen-Targeted Neoantigen mRNA Vaccines Drive TLS in HCC

  2026-06-25

  Lin et al. demonstrate that a spleen-targeted neoantigen mRNA vaccine (STNvac) potently induces ISG15+ CD8+ T cells and tertiary lymphoid structure (TLS) formation in hepatocellular carcinoma (HCC). This study reveals new mechanisms for overcoming immune resistance in HCC, providing a strategic framework for organ-targeted mRNA immunotherapy.

• CBD Modulates Pain and Emotion via Endocannabinoid and Serot

  2026-06-24

  This study demonstrates that cannabidiol (CBD) robustly alleviates both sensory and affective dimensions of orofacial inflammatory pain in mice. Through integrated behavioral, molecular, and circuit-level approaches, the researchers reveal that CBD acts via coordinated modulation of endocannabinoid and serotonergic systems, suggesting new translational strategies for pain and emotional comorbidity management.

496 records 9/34 page Previous Next First page 上5页 678910 下5页 Last page